Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ELOS's 30-Y Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2017

ELOS Guru Trades in Q1 2017

Discovery Group I, LLC 1,221,310 sh (New)
Charles Brandes 3,680,764 sh (+0.55%)
Mario Gabelli 24,000 sh (unchged)
Chuck Royce 69,200 sh (unchged)
Jim Simons 1,104,580 sh (-3.23%)
» More
Q2 2017

ELOS Guru Trades in Q2 2017

Mario Gabelli 72,700 sh (+202.92%)
Chuck Royce 69,200 sh (unchged)
Discovery Group I, LLC Sold Out
Charles Brandes 3,455,097 sh (-6.13%)
Jim Simons 580,780 sh (-47.42%)
» More
Q3 2017

ELOS Guru Trades in Q3 2017

Jim Simons Sold Out
Mario Gabelli Sold Out
Chuck Royce Sold Out
Charles Brandes 2,901,971 sh (-16.01%)
» More
Q4 2017

ELOS Guru Trades in Q4 2017

Charles Brandes Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with ELOS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices  
Compare:XKRX:085370, ROCO:4736, XKRX:099190, NAS:GNMK, XKRX:060280, NAS:TNDM, NAS:ARAY, HKSE:01696, OSTO:HANDI, XKRX:086890, HKSE:01358, XKRX:228850, OSTO:XVIVO, SZSE:300216, HKSE:03600, XKRX:054950, XKRX:042520, HKSE:01789, NAS:RTIX, ROCO:4107 » details
Traded in other countries:FGD.Germany,
Headquarter Location:Israel
Syneron Medical Ltd designs, develops & markets aesthetic medical products based on its proprietary technologies. Its offers Skin Rejuvenation, Age Spots, Cellulite Reduction, Acne among others.

Syneron Medical Ltd., was incorporated in the State of Israel in July 2000. The Company completed its initial public offering of ordinary shares in August 2004. It designs, develops and markets aesthetic medical products based on its various technologies including its proprietary Electro-Optical Synergy, or ELOS, technology, which uses the synergy between electrical energy, including radiofrequency or RF energy, and optical energy to provide effective, safe and affordable aesthetic medical treatments. The Company's products, which it sells mainly to physicians and other practitioners, target non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin and laser-assisted lipolysis and topical skin brightening products.



Buy Back


Valuation & Return


More Statistics

Revenue (TTM) (Mil) $296.29
EPS (TTM) $ -0.11
52-Week Range $6.18 - 11.43
Shares Outstanding (Mil)35.23

Analyst Estimate

Revenue (Mil $)
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) 0.23
EPS without NRI ($) 0.23
EPS Growth Rate
(Future 3Y To 5Y Estimate)
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat